Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 343 results found. Search for [ moderna vaccine ]

Results 1 to 21 of 343
Associated Press
November 30, 2020
Multiple vaccine candidates must succeed for the world to stamp out the pandemic, which has been on the upswing in the US and Europe. US hospitals have been stretched to the limit as the nation has seen more than 160,000 new cases per day


Chitranjan Kumar
November 30, 2020
Primary efficacy analysis of the Phase 3 COVE study of Moderna' COVID-19 vaccine involved 30,000 participants included 196 cases of COVID-19, of which 30 cases were severe


BusinessToday.In
November 30, 2020
Disclosing a list of related party transactions on the BSE, Mukesh Ambani-led Reliance mentioned Actoserba Active Wholesale as an associate company


BusinessToday.In
November 30, 2020
There are only five companies that have given preliminary data about how effective their vaccines could be to fight against coronavirus. These five companies include Pfizer-BioTech, Moderna Inc, Oxford University-AstraZeneca Plc, and Gamaleya Institute


BusinessToday.In
November 29, 2020
As coronavirus cases continue to rise, the UK plans to move fast in the approval process and clearance to Pfizer and BioNTech SE could come by next week


PB Jayakumar
November 28, 2020
Serum Institute will have a capacity to make over 2.5 billion doses of vaccines a year as it is currently upscaling the capacity from over 1.6 billion doses  


Reuters
November 28, 2020
If a vaccine has an efficacy of, say, 80%, it means that if 100 people who have not previously been infected by the coronavirus are given the vaccine, on average 80 of them will not get the disease that the virus causes: COVID-19


Reuters
November 28, 2020
Vaccines by Pfizer and BioNtech, as well as Moderna and AstraZeneca have shown promising results in large clinical trials, but there is no question of \"cutting corners\", said Thomas Cueni, director-general of the IFPMA


BusinessToday.In
November 27, 2020
After the publication of early data from phase-3 clinical trials, drugmakers Pfizer and BioNTech have sought regulatory approval to deploy their inoculation under emergency-use rules. American biotech company Moderna is also likely to do the same soon


Manoj Sharma
November 27, 2020
New vaccines are rarely certified for efficacy above 90 per cent. Their efficacy improves as millions are vaccinated over decades. In fact, most vaccines get certified in the 40-60 per cent efficacy band


BusinessToday.In
November 27, 2020
The company could be looking at manufacturing 100 million doses to begin with, as per Chairman Pankaj Patel.


BusinessToday.In
November 26, 2020
SII has partnered with AstraZeneca and Oxford University for the manufacturing and distribution of its COVID-19 vaccine candidate 'Covishield' in India and other countries


BusinessToday.In
November 25, 2020
The International Air Transport Association is working on mobile app, which will act as a digital passport. The app will enclose COVID-19 test and vaccination certificates to provide a smooth travelling experience for airline passengers


Rajeev Dubey
New Delhi, November 25, 2020
In stark contrast to the mayhem around the world, India's top three candidates - Serum-Oxford, Bharat Biotech and Zydus Cadila continued their scientific pursuits unobtrusively (the fourth, DRL-Gamaleya, just started India trials). At least 16 more vaccines are under development at home


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
A blow-by-blow account of how Indian vaccines are being readied


Aseem Thapliyal
November 25, 2020
Sensex climbed 302 points to 44,825 and Nifty gained 90 points to 13,145


Reuters
November 24, 2020
Brent crude rose 51 cents, or 1.1%, to $46.57 a barrel by 1322 GMT and hit a session high of $46.72, its highest since March 6. U.S. West Texas Intermediate crude gained 63 cents, or 1.5%, to $43.69


BusinessToday.In
November 24, 2020
Frontline health workers to receive vaccines first, followed by police personnel and sanitation workers in the second stage


BusinessToday.In
November 24, 2020
Vardhan says it makes no sense to consider Pfizer as pharma major is yet to get approval in the US. After requisite approvals, US pharma major will have to cater to needs of its own country's population first


BusinessToday.In
November 23, 2020
Centre is worried about the caseload surge in urban centres, which has resulted in the enforcement of measures such as curfews by state governments.


PAGES 1 OF 18  12345